
Eli Lilly and Company statistics
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.37T
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Eli Lilly and Company is valued at $1.37T on its latest close. Its price is 49.6 times its earnings.
| Market value | $1.37T |
|---|
| Enterprise value | $1.40T |
|---|
| Price / earnings | 49.57 |
|---|
| Price / sales | 15.81 |
|---|
| Price / book | 33.95 |
|---|
| EV / EBITDA | 37.74 |
|---|
| EV / sales | 16.22 |
|---|
| Price / free cash flow | 69.54 |
|---|
| Price / free cash flow, own 5-year average | 282.76 |
|---|
| EV / EBIT | 40.35 |
|---|
| EV / free cash flow | 71.81 |
|---|
| Free cash flow yield | 1.4% |
|---|
| Dividend yield | 0.4% |
|---|
Share price
| Latest close | $1443.50 |
|---|
| Day's change | +1.1% |
|---|
| 52-week high | $1460.00 |
|---|
| 52-week low | $850.51 |
|---|
| From 52-week high | −1.1% |
|---|
| Return · 1 month | +14.8% |
|---|
| Return · 3 months | +16.0% |
|---|
| Return · year to date | +34.3% |
|---|
| Return · 1 year | +41.8% |
|---|
| Beta · 1 year against the S&P 500 | 0.30 |
|---|
| 50-day average | $1241.10 |
|---|
| 200-day average | $1109.30 |
|---|
| RSI 14 | 69.7 |
|---|
| Average volume · 20 sessions | 3.0M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 83.0% |
|---|
| Operating margin | 40.9% |
|---|
| Net margin | 31.7% |
|---|
| Free cash flow margin | 13.8% |
|---|
| Return on equity | 101% |
|---|
| Return on assets | 22.3% |
|---|
| Return on invested capital | 34.4% |
|---|
| Return on invested capital, 5-year average | 22.3% |
|---|
| Return on capital employed | 41.7% |
|---|
| Stock-based compensation / revenue | 1.0% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $7.27B |
|---|
| Total debt | $43.87B |
|---|
| Net debt | $36.60B |
|---|
| Current ratio | 1.58 |
|---|
| Quick ratio | 0.57 |
|---|
| Debt / equity | 1.65 |
|---|
| Net debt / EBITDA | 1.28 |
|---|
| Interest coverage | 29.75 |
|---|
Growth
| Revenue, latest quarter on a year | +38.6% |
|---|
| Revenue, twelve months on a year | +45.5% |
|---|
| EPS, latest quarter on a year | +16.3% |
|---|
| EPS, twelve months on a year | +50.7% |
|---|
| Revenue, 5-year compound | +21.6% |
|---|
| Revenue, 10-year compound | +12.6% |
|---|
| Net income, 5-year compound | +27.2% |
|---|
| Free cash flow, 5-year compound | +11.9% |
|---|
| EPS, 5-year compound | +27.6% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 899M |
|---|
| Shares outstanding, 5-year compound | −0.3% |
|---|
| Net share repurchases | $4.11B |
|---|
| Dividends per share | $6.23 |
|---|
| Dividend payout | 26.1% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $5.09B |
|---|
| Effective tax rate | 19.8% |
|---|
LLY in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.